Release Date: 01/08/22 07:53 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 210.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%